Covered recipient · General Payments record
REFAT BARIDI
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2019–2025
$6,188.09
- Reported across 268 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,403.32 | 58 |
| Education | $168.99 | 3 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $161.28 | 7 |
| Merck Sharp & Dohme Corporation | $135.51 | 6 |
| GlaxoSmithKline, LLC. | $118.90 | 6 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $101.35 | 4 |
| Incyte Corporation | $99.00 | 1 |
| Gilead Sciences, Inc. | $97.85 | 3 |
| TerSera Therapeutics LLC | $80.40 | 3 |
| PFIZER INC. | $77.60 | 4 |
| Celgene Corporation | $76.54 | 3 |
| E.R. Squibb & Sons, L.L.C. | $67.50 | 2 |
| AVEO Pharmaceuticals, Inc. | $52.13 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $49.88 | 2 |
| GENZYME CORPORATION | $41.14 | 2 |
| Celltrion USA Inc. | $40.75 | 1 |
| BeiGene USA, Inc. | $38.37 | 1 |
| Deciphera Pharmaceuticals Inc. | $32.28 | 1 |
| Daiichi Sankyo Inc. | $29.76 | 1 |
| Fresenius Kabi USA, LLC | $29.33 | 1 |
| Karyopharm Therapeutics Inc. | $28.52 | 1 |
| Janssen Biotech, Inc. | $28.47 | 1 |
| Astellas Pharma US Inc | $28.02 | 1 |
| Amneal Pharmaceuticals LLC | $25.89 | 1 |
| Sumitomo Pharma America, Inc. | $24.61 | 1 |
| ARRAY BIOPHARMA INC | $21.51 | 1 |
| Stemline Therapeutics Inc. | $19.08 | 1 |
| Alexion Pharmaceuticals, Inc. | $17.16 | 1 |
| Immunocore Limited | $17.12 | 1 |
| ABBVIE INC. | $16.77 | 1 |
| Genentech USA, Inc. | $15.59 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (61)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.